Inovio Pharmaceuticals Inc. closed 85.15% below its 52-week high of $14.75, which the company reached on April 1st.

Inovio Pharmaceuticals Inc. closed 84.61% short of its 52-week high of $14.75, which the company reached on April 1st.

The company priced a public offering of 10 million shares of common stock and accompanying warrants. Inovio Pharmaceuticals Inc INO shares are trading lower by 40% to $2.23 during Friday’s ...

Inovio Pharmaceuticals (NASDAQ:INO – Get Free Report)‘s stock had its “market outperform” rating restated by JMP Securities in a report issued on Friday,Benzinga reports. They currently have a $18.00 ...

Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting ...

Analysts at HC Wainwright upped their FY2024 earnings estimates for Inovio Pharmaceuticals in a research report issued on ...

Inovio Pharmaceuticals Inc INO shares are trading higher by 17.9% ... ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock ...

Like most office property landlords, INO has had a few rough years. Data by YCharts We started covering this stock in December 2022. Its downward spiral was well underway at that time, with one of ...

Nasdaq provides an interactive stock information chart to view history. Downloadable stock history data table is also accessible by clicking on Data Table on the navigation tool bar. If you have ...